Evenity Will Be a New Injectable for Postmenopausal Osteoporosis

Some postmenopausal women will get Evenity (ee-VEN-ih-tee, romosozumab), a new injectable med for osteoporosis.

Evenity increases bone growth AND decreases bone breakdown. Other osteoporosis meds (alendronate, Forteo, etc) do one OR the other.

Expect Evenity to be saved for high-risk women...such as those with a prior fracture on a bisphosphonate (alendronate, etc) or with multiple spine fractures.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote